YIDU TECH (02158) profit pre-announcement: Net profit for the fiscal year 2026 is expected to be between 55 million and 70 million yuan. "AI orders" are strong.

On April 20th, the leading medical AI company YIDU TECH (02158) released a positive profit forecast, expecting a net profit of 55 to 70 million RMB for the 2026 fiscal year (ending on March 31, 2026), achieving the company's first full year profit since its establishment. In the 2025 fiscal year, the company had a net loss of 135 million RMB. This milestone breakthrough signifies that YIDU TECH has officially crossed the key turning point from "burning money layout" to "self-sufficiency" phase. The board of directors believes that this key performance turning point is mainly attributed to the continuous upgrades of the company's products integrating AI capabilities, effectively enhancing the product value proposition and market competitiveness, driving significant growth in new orders for the core business sector. The increase in gross profit margin is the result of the upgraded products integrated with AI having higher added value, improved operational efficiency, and the combined effect of economies of scale. In terms of news, the clinical evidence-based intelligent system "Yedu Zhi Xun" has continuously received heavy recognition and market breakthroughs since its release. On March 10th, YIDU TECH officially launched this doctor-exclusive evidence-based AI assistant, which quickly attracted over 6000 healthcare professionals to participate actively during the testing phase, receiving nearly 2000 pieces of professional and effective feedback. On March 26th, the Yedu Zhi Xun APP version was officially launched during the 2026 Beijing Centergate Technologies forum annual meeting, simultaneously initiating the "China Clinical Evidence-Based Intelligent System Building Plan" jointly launched by multiple top medical institutions with YIDU TECH providing core AI support, further solidifying its leading position in the medical evidence-based AI field. In early April, Yedu Zhi Xun, with its strong technical strength and mature implementation capabilities, successfully made it to the "Top 100 Industry-level Intelligent Systems of 2026" and the "2026 National Enterprise 'AI +' Action Innovation Case", with its solution based on the evidence-based engine already deployed in more than 40 Class A hospitals, deeply involved in over 500,000 clinical decision-making processes and gaining high recognition from authoritative institutions such as Peking Union Medical College Hospital and Sun Yat-sen University Cancer Center. In terms of business expansion, YIDU TECH recently successively released bid-winning announcements: on April 8th, the announcement of winning the Beijing Cancer Hospital AI construction project jointly with Bank of China Medical was seen as a key milestone for the landing of large models of medical AI in the field of oncology, setting a benchmark for industry-scale application. Just 5 days later, the company announced winning the bid for the Hainan Province Integrated Regional Infectious Disease Surveillance Early Warning and Emergency Command Information Platform (Phase II) project with nearly 12.89 million RMB, further consolidating its leading advantage in the field of provincial public health digitization. The successful implementation of the two major projects fully confirms the company's core competitive strength in AI technology in clinical and public health scenarios, driving synergies between ToB and ToG businesses. The capital market and authoritative institutions continue to release positive signals, injecting strong confidence into the company's development. Recently, Citibank released a research report, reiterating a "buy" rating for YIDU TECH with a target price of 11 Hong Kong dollars, pointing out that the launch of Yedu Zhi Xun will effectively deepen the company's connection with the medical community and strengthen the big data platform and solution business. In addition, several institutions including Northeast also gave a "hold" rating, recognizing the company's technological barriers and the accelerating trend towards commercialization. With the large-scale promotion of Yedu Zhi Xun, the continuous landing of benchmark projects, and the overall improvement in profitability, YIDU TECH is accelerating towards a high-quality development stage, moving from technological leadership to profit realization.